Ignite Creation Date:
2024-05-06 @ 1:48 PM
Last Modification Date:
2024-10-26 @ 1:20 PM
Study NCT ID:
NCT04123795
Status:
RECRUITING
Last Update Posted:
2024-03-29
First Post:
2019-10-09
Brief Title:
A Study to Evaluate the Efficacy Safety and Drug Concentration of Certolizumab Pegol CZP in Children and Adolescent Study Participants With Moderate to Severe Chronic Plaque Psoriasis PSO
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Organization Data
Organization:
UCB Pharma
Class:
INDUSTRY
Study ID:
PS0007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UCB Biopharma SRL
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None